279 Liver disease in pediatric patients treated at the Cystic Fibrosis Centre of the University Hospital Centre Zagreb

Authors:

Abstract
Objective To describe the characteristics of patients with cystic fibrosis-associated liver disease (CFLD), a complication of cystic fibrosis (CF) that is often asymptomatic until an advanced stage. Methods Retrospective analysis included patients aged 0-20 years followed in 2018. at the Cystic Fibrosis Centre of the University Hospital Centre Zagreb. CFLD1 was diagnosed if ≥2 of the following were present: hepatomegaly and/or splenomegaly, elevated transaminases or gamma-glutamyl transferase (GGT) 3 times during 12 months, ultrasound signs of liver involvement or portal hypertension (PTH), suggestive pathohistological findings. Severe CFLD was defined as a disease with signs of PTH. Results 61 patients with a mean age of 10.9 years (9 months-19 years, male: female = 34:27) were included. 9/61 (14.8%) of them had CFLD, 6 girls and 3 boys, aged 2-19 years (average age 10.7 years). They all had at least one F508del mutation, and 7/9 were homozygous. Regarding the severity of the disease, 4 patients (3 boys and 1 girl, 6-19 years) had a severe form of CFLD with PTH and presumed cirrhosis, which was confirmed by liver biopsy in one patient. Two patients also had impaired synthetic liver function, two had hypersplenism with platelet count Conclusion The diversity of clinical expression and findings in our patients is consistent with the literature data on the spectrum of CFLD manifestations. We confirmed a higher incidence of meconium ileus and severe mutations, and male dominance in CFLD with PTH. In all CF patients, liver disease should be actively sought from an early age (clinical examination once a year + abdominal ultrasound + AST, ALT, GGT).